Log in or Sign up for Free to view tailored content for your specialty!
Pediatric Endocrinology News
Novel therapies targeting bile acid-triggered pathways may benefit children with NASH
Medications that target bile acid-triggered pathways and combination therapies could be the key for treating nonalcoholic steatohepatitis for young people with obesity and type 2 diabetes, according to a speaker.
Transgender young people report worse mental health than general population
Transgender and gender-expansive young people report worse quality of life mental health scores compared with the general U.S. population, according to study data.
Log in or Sign up for Free to view tailored content for your specialty!
Addressing pediatric obesity: The crucial role of parenting
Pediatric obesity has become a significant health concern in recent years, with the prevalence reaching higher levels. It is a complex condition influenced by various factors, including genetics, lifestyle choices and environmental factors.
Diabetes in pregnancy associated with common neonatal morbidities
Diabetes in pregnancy is associated with a higher likelihood of common neonatal comorbidities in babies born moderately or late-preterm, such as a need for respiratory support, according to a study published in Pediatrics.
CGM use less likely for children with type 1 diabetes living in rural vs. urban areas
Children with type 1 diabetes living in small or isolated rural towns are less likely to use continuous glucose monitoring than those living in urban areas, according to data published in Diabetes Care.
Bone density rebounds for transgender people during gender-confirming hormone therapy
Transgender people who use gender-confirming hormone therapy long term have increases in bone mineral density back to levels observed before pubertal suppression, according to findings published in JAMA Pediatrics.
Investigational oral therapy increases height velocity for children with GH deficiency
An oral medication under investigation for treating pediatric GH deficiency boosted annualized height velocity at 6 and 12 months for children, according to topline results from two phase 2 trials.
Teplizumab preserves beta-cell function for children with new-onset type 1 diabetes
Children with new-onset type 1 diabetes had better preservation of beta-cell function with two 12-day courses of teplizumab compared with those receiving placebo, according to findings published in The New England Journal of Medicine.
FDA expands indication for vosoritide to include children of all ages with achondroplasia
The FDA has expanded its accelerated approval of an injectable therapy for treating achondroplasia to include children of all ages, according to a press release.
Setmelanotide may cut metabolic syndrome risk in rare monogenic forms of obesity
DALLAS — People with rare monogenic forms of obesity may reduce their risk for metabolic syndrome with setmelanotide therapy, according to research presented at ObesityWeek.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read